drugset / Trial / NCT03756246

Influenza Vaccine as a Novel Experimental Model of the Behavioral Immune Response in Depression

NCT03756246

Phase 4 Unknown 75 enrolled University of Texas at Austin
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

The purpose of this study is to determine differences between the immune responses in healthy and depressed people. Participants will receive the influenza vaccine and their responses will be monitored. This study will recruit 15 healthy and 60 depressed participants.

Timeline

Start
2019-06-10
Primary completion
2020-05
Completion
2021-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine Intramuscular

Indications